Acquisition by David Ramsay of 22500 shares of Savara subject to Rule 16b-3

SVRA Stock  USD 3.36  0.20  5.62%   
About 61% of Savara's investor base is looking to short. The analysis of the overall investor sentiment regarding Savara Inc suggests that many traders are alarmed. The current market sentiment, together with Savara's historical and current headlines, can help investors time the market. In addition, many technical investors use Savara Inc stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Savara Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at news.google.com
Google News at Macroaxis
  
Savara insider trading alert for grant of common stock by David Ramsay, the corporate stakeholder, on 15th of December 2023. This event was filed by Savara Inc with SEC on 2023-12-15. Statement of changes in beneficial ownership - SEC Form 4

Savara Fundamental Analysis

We analyze Savara's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Savara using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Savara based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

Savara is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Savara Inc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Savara stock to make a market-neutral strategy. Peer analysis of Savara could also be used in its relative valuation, which is a method of valuing Savara by comparing valuation metrics with similar companies.

Peers

Savara Related Equities

PTIXProtagenic Therapeutics   5.77   
0%
17.0%
ACLXArcellx   5.73   
0%
17.0%
IKNAIkena Oncology   1.80   
0%
5.0%
FENCFennec Pharmaceuticals   1.32   
0%
4.0%
EWTXEdgewise Therapeutics   1.15   
0%
3.0%
CRNXCrinetics Pharmaceuticals   0.97   
0%
2.0%
XOMAOXOMA   0.40   
0%
1.0%
XOMAXOMA Corp   0.47   
1.0%
0%
KZRKezar Life   0.86   
2.0%
0%
AVTEAerovate Therapeutics   1.14   
3.0%
0%
GPCRStructure Therapeutics   1.30   
3.0%
0%
RZLTRezolute   1.39   
4.0%
0%
RVMDRevolution Medicines   1.82   
5.0%
0%
STOKStoke Therapeutics   2.11   
6.0%
0%
XLOXilio Development   2.80   
8.0%
0%
TRDAEntrada Therapeutics   2.97   
9.0%
0%
DYNDyne Therapeutics   3.04   
9.0%
0%
ALXOAlx Oncology   4.43   
13.0%
0%
TPSTTempest Therapeutics   4.49   
13.0%
0%
SRRKScholar Rock   5.26   
16.0%
0%
TARAProtara Therapeutics   6.30   
19.0%
0%
ANABAnaptysBio   32.83   
100.0%
0%

Complementary Tools for Savara Stock analysis

When running Savara's price analysis, check to measure Savara's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Savara is operating at the current time. Most of Savara's value examination focuses on studying past and present price action to predict the probability of Savara's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Savara's price. Additionally, you may evaluate how the addition of Savara to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Valuation
Check real value of public entities based on technical and fundamental data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum